Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infection.
Park H, Nakamura N, Miyamoto S, Sato Y, Kim KS, Kitagawa K, Kobashi Y, Tani Y, Shimazu Y, Zhao T, Nishikawa Y, Omata F, Kawashima M, Abe T, Saito Y, Nonaka S, Takita M, Yamamoto C, Morioka H, Kato K, Sagou K, Yagi T, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Shibata RY, Aihara K, Kodama T, Kamiyama A, Tamura T, Fukuhara T, Shibuya K, Suzuki T, Iwami S, Tsubokura M.
Park H, et al. Among authors: takita m.
Sci Transl Med. 2025 Sep 17;17(816):eadv4214. doi: 10.1126/scitranslmed.adv4214. Epub 2025 Sep 17.
Sci Transl Med. 2025.
PMID: 40961221